Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines ; day:15 ; month:5 ; year:2024 ; pages:1-14
Naunyn-Schmiedeberg's archives of pharmacology ; (15.5.2024), 1-14
- Urheber
-
Zehra, Kanli
Banu, Aydin
Can, Erzik
Hülya, Cabadak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00210-024-03145-0
- URN
-
urn:nbn:de:101:1-2407242107081.781142918111
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:54 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zehra, Kanli
- Banu, Aydin
- Can, Erzik
- Hülya, Cabadak
- SpringerLink (Online service)
Ähnliche Objekte (12)
Capecitabine-Associated Terminal Ileitis
Photosensitive lichenoid skin reaction to capecitabine
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adherence Management for Cancer Patients on Capecitabine
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Oromandibular dystonia: a serious side effect of capecitabine
Hepatic steatosis secondary to capecitabine: a case report
Capecitabine-Related Fourth Nerve Palsy: A Case Report
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine-induced severe diabetes and hypokalemia: a case report
Capecitabine in the treatment of metastatic renal cell carcinoma
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Capecitabine-Associated Terminal Ileitis
Photosensitive lichenoid skin reaction to capecitabine
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adherence Management for Cancer Patients on Capecitabine
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Oromandibular dystonia: a serious side effect of capecitabine
Hepatic steatosis secondary to capecitabine: a case report
Capecitabine-Related Fourth Nerve Palsy: A Case Report
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine-induced severe diabetes and hypokalemia: a case report
Capecitabine in the treatment of metastatic renal cell carcinoma
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Capecitabine-Associated Terminal Ileitis
Photosensitive lichenoid skin reaction to capecitabine
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adherence Management for Cancer Patients on Capecitabine
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Oromandibular dystonia: a serious side effect of capecitabine
Hepatic steatosis secondary to capecitabine: a case report
Capecitabine-Related Fourth Nerve Palsy: A Case Report
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine-induced severe diabetes and hypokalemia: a case report
Capecitabine in the treatment of metastatic renal cell carcinoma